Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1161/circheartfailure.122.010051
Background: Inflammation may play a role in the pathophysiology of heart failure with preserved ejection fraction. We examined whether circulating levels of interleukin-6 identify patients at greater risk of adverse outcomes following hospitalization with heart failure with preserved ejection fraction. Methods: We assessed relationships between interleukin-6 (IL-6) tertiles (T1-3) and all-cause death, cardiovascular death, and subsequent heart failure hospitalization (sHFH) in 286 patients recently hospitalized with heart failure with preserved ejection fraction. Associations between IL (interleukin)-6 and outcomes were examined in a Cox-regression model adjusted for risk factors including BNP (B-type natriuretic peptide). Biomarkers including hsCRP (high-sensitivity C-reactive protein) were assessed. Results: The range of IL-6 (pg/mL) in each tertile was T1 (0.71–4.16), T2 (4.20–7.84), and T3 (7.9–236.32). Compared with T1, patients in the highest IL-6 tertile were more commonly male (56% versus 35%) and had higher creatinine (117±45 versus 101±36 μmol/L), hsCRP (11.6 [4.9–26.6]mg/L versus 2.3[1.1–4.2] mg/L). In univariable analysis, rates of all-cause death, cardiovascular death, and sHFH were higher in T3 versus T1. All-cause and cardiovascular death rates remained higher in T3 versus T1 after adjustment ( P <0.001). One log unit increase in IL-6 was associated with higher risk of all-cause death (hazard ratio, 1.46 [1.17–1.81]), cardiovascular death (hazard ratio, 1.40 [1.10–1.77]), and sHFH (hazard ratio, 1.24 [1.01–1.51]) after adjustment. One log unit increase in hsCRP was associated with a higher risk of cardiovascular death and all-cause death before and after adjustment for other factors but was not associated with risk of sHFH before or after adjustment. Conclusions: In patients recently hospitalized with heart failure with preserved ejection fraction, IL-6 is an independent predictor of all-cause mortality, cardiovascular death, and sHFH after adjustment for risk factors including BNP. These findings are of particular relevance in the context of current anti–IL-6 drug development.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1161/circheartfailure.122.010051
- https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051
- OA Status
- hybrid
- Cited By
- 41
- References
- 41
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4323807518
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4323807518Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1161/circheartfailure.122.010051Digital Object Identifier
- Title
-
Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection FractionWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-10Full publication date if available
- Authors
-
Leanne Mooney, Colette E. Jackson, Carly Adamson, Alex McConnachie, Paul Welsh, Rachel C. Myles, John J.V. McMurray, Pardeep S. Jhund, Mark C. Petrie, Ninian N. LangList of authors in order
- Landing page
-
https://doi.org/10.1161/circheartfailure.122.010051Publisher landing page
- PDF URL
-
https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051Direct OA link when available
- Concepts
-
Medicine, Ejection fraction, Heart failure, Hazard ratio, Internal medicine, Cardiology, Natriuretic peptide, Creatinine, Heart failure with preserved ejection fraction, Proportional hazards model, Cause of death, Confidence interval, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
41Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 14, 2024: 20, 2023: 7Per-year citation counts (last 5 years)
- References (count)
-
41Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4323807518 |
|---|---|
| doi | https://doi.org/10.1161/circheartfailure.122.010051 |
| ids.doi | https://doi.org/10.1161/circheartfailure.122.010051 |
| ids.openalex | https://openalex.org/W4323807518 |
| fwci | 13.76439206 |
| type | article |
| title | Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction |
| biblio.issue | 4 |
| biblio.volume | 16 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10198 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Heart Failure Treatment and Management |
| topics[1].id | https://openalex.org/T11962 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9994999766349792 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Cardiac Fibrosis and Remodeling |
| topics[2].id | https://openalex.org/T12598 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9944999814033508 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Cardiac Structural Anomalies and Repair |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8201674818992615 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C78085059 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8138885498046875 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q641303 |
| concepts[1].display_name | Ejection fraction |
| concepts[2].id | https://openalex.org/C2778198053 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7978833317756653 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q181754 |
| concepts[2].display_name | Heart failure |
| concepts[3].id | https://openalex.org/C207103383 |
| concepts[3].level | 3 |
| concepts[3].score | 0.7538101673126221 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[3].display_name | Hazard ratio |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.7190774083137512 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C164705383 |
| concepts[5].level | 1 |
| concepts[5].score | 0.6173930168151855 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[5].display_name | Cardiology |
| concepts[6].id | https://openalex.org/C2775915353 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5901334881782532 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1571529 |
| concepts[6].display_name | Natriuretic peptide |
| concepts[7].id | https://openalex.org/C2780306776 |
| concepts[7].level | 2 |
| concepts[7].score | 0.512461245059967 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q426660 |
| concepts[7].display_name | Creatinine |
| concepts[8].id | https://openalex.org/C2777099384 |
| concepts[8].level | 4 |
| concepts[8].score | 0.49331608414649963 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3799239 |
| concepts[8].display_name | Heart failure with preserved ejection fraction |
| concepts[9].id | https://openalex.org/C50382708 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4682256877422333 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q223218 |
| concepts[9].display_name | Proportional hazards model |
| concepts[10].id | https://openalex.org/C29374701 |
| concepts[10].level | 3 |
| concepts[10].score | 0.44981130957603455 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1931388 |
| concepts[10].display_name | Cause of death |
| concepts[11].id | https://openalex.org/C44249647 |
| concepts[11].level | 2 |
| concepts[11].score | 0.1603611707687378 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[11].display_name | Confidence interval |
| concepts[12].id | https://openalex.org/C2779134260 |
| concepts[12].level | 2 |
| concepts[12].score | 0.15681743621826172 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[12].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8201674818992615 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/ejection-fraction |
| keywords[1].score | 0.8138885498046875 |
| keywords[1].display_name | Ejection fraction |
| keywords[2].id | https://openalex.org/keywords/heart-failure |
| keywords[2].score | 0.7978833317756653 |
| keywords[2].display_name | Heart failure |
| keywords[3].id | https://openalex.org/keywords/hazard-ratio |
| keywords[3].score | 0.7538101673126221 |
| keywords[3].display_name | Hazard ratio |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.7190774083137512 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/cardiology |
| keywords[5].score | 0.6173930168151855 |
| keywords[5].display_name | Cardiology |
| keywords[6].id | https://openalex.org/keywords/natriuretic-peptide |
| keywords[6].score | 0.5901334881782532 |
| keywords[6].display_name | Natriuretic peptide |
| keywords[7].id | https://openalex.org/keywords/creatinine |
| keywords[7].score | 0.512461245059967 |
| keywords[7].display_name | Creatinine |
| keywords[8].id | https://openalex.org/keywords/heart-failure-with-preserved-ejection-fraction |
| keywords[8].score | 0.49331608414649963 |
| keywords[8].display_name | Heart failure with preserved ejection fraction |
| keywords[9].id | https://openalex.org/keywords/proportional-hazards-model |
| keywords[9].score | 0.4682256877422333 |
| keywords[9].display_name | Proportional hazards model |
| keywords[10].id | https://openalex.org/keywords/cause-of-death |
| keywords[10].score | 0.44981130957603455 |
| keywords[10].display_name | Cause of death |
| keywords[11].id | https://openalex.org/keywords/confidence-interval |
| keywords[11].score | 0.1603611707687378 |
| keywords[11].display_name | Confidence interval |
| keywords[12].id | https://openalex.org/keywords/disease |
| keywords[12].score | 0.15681743621826172 |
| keywords[12].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1161/circheartfailure.122.010051 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S8311976 |
| locations[0].source.issn | 1941-3289, 1941-3297 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1941-3289 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Circulation Heart Failure |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Circulation: Heart Failure |
| locations[0].landing_page_url | https://doi.org/10.1161/circheartfailure.122.010051 |
| locations[1].id | pmh:oai:eprints.gla.ac.uk:292610 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306400411 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | Enlighten: Publications (The University of Glasgow) |
| locations[1].source.host_organization | https://openalex.org/I7882870 |
| locations[1].source.host_organization_name | University of Glasgow |
| locations[1].source.host_organization_lineage | https://openalex.org/I7882870 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | acceptedVersion |
| locations[1].raw_type | PeerReviewed |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | http://eprints.gla.ac.uk/view/author/51811.html>, |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10101136 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10101136/pdf/hhf-16-e010051.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Circ Heart Fail |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10101136 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5090522431 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3942-5589 |
| authorships[0].author.display_name | Leanne Mooney |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[0].affiliations[0].raw_affiliation_string | Leanne Mooney https://orcid.org/0000-0002-3942-5589 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[0].institutions[0].id | https://openalex.org/I7882870 |
| authorships[0].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | University of Glasgow |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Leanne Mooney |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Leanne Mooney https://orcid.org/0000-0002-3942-5589 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[1].author.id | https://openalex.org/A5034402860 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-7814-0749 |
| authorships[1].author.display_name | Colette E. Jackson |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[1].affiliations[0].raw_affiliation_string | Colette E. Jackson School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[1].institutions[0].id | https://openalex.org/I7882870 |
| authorships[1].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University of Glasgow |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Colette E. Jackson |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Colette E. Jackson School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[2].author.id | https://openalex.org/A5028896487 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7019-7329 |
| authorships[2].author.display_name | Carly Adamson |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[2].affiliations[0].raw_affiliation_string | Carly Adamson https://orcid.org/0000-0001-7019-7329 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[2].institutions[0].id | https://openalex.org/I7882870 |
| authorships[2].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | University of Glasgow |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Carly Adamson |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Carly Adamson https://orcid.org/0000-0001-7019-7329 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[3].author.id | https://openalex.org/A5078354802 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7262-7000 |
| authorships[3].author.display_name | Alex McConnachie |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[3].affiliations[0].raw_affiliation_string | Alex McConnachie https://orcid.org/0000-0002-7262-7000 Robertson Centre for Biostatistics (A.M.), University of Glasgow, United Kingdom. |
| authorships[3].institutions[0].id | https://openalex.org/I7882870 |
| authorships[3].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | University of Glasgow |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Alex McConnachie |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Alex McConnachie https://orcid.org/0000-0002-7262-7000 Robertson Centre for Biostatistics (A.M.), University of Glasgow, United Kingdom. |
| authorships[4].author.id | https://openalex.org/A5021225266 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7970-3643 |
| authorships[4].author.display_name | Paul Welsh |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[4].affiliations[0].raw_affiliation_string | Paul Welsh https://orcid.org/0000-0002-7970-3643 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[4].institutions[0].id | https://openalex.org/I7882870 |
| authorships[4].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | University of Glasgow |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Paul Welsh |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Paul Welsh https://orcid.org/0000-0002-7970-3643 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[5].author.id | https://openalex.org/A5042097559 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4670-361X |
| authorships[5].author.display_name | Rachel C. Myles |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[5].affiliations[0].raw_affiliation_string | Rachel C. Myles https://orcid.org/0000-0003-4670-361X School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[5].institutions[0].id | https://openalex.org/I7882870 |
| authorships[5].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | University of Glasgow |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Rachel C. Myles |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Rachel C. Myles https://orcid.org/0000-0003-4670-361X School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[6].author.id | https://openalex.org/A5027213857 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6317-3975 |
| authorships[6].author.display_name | John J.V. McMurray |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[6].affiliations[0].raw_affiliation_string | John J.V. McMurray https://orcid.org/0000-0002-6317-3975 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[6].institutions[0].id | https://openalex.org/I7882870 |
| authorships[6].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | University of Glasgow |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | John J.V. McMurray |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | John J.V. McMurray https://orcid.org/0000-0002-6317-3975 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[7].author.id | https://openalex.org/A5018432247 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-4306-5317 |
| authorships[7].author.display_name | Pardeep S. Jhund |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[7].affiliations[0].raw_affiliation_string | Pardeep S. Jhund https://orcid.org/0000-0003-4306-5317 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[7].institutions[0].id | https://openalex.org/I7882870 |
| authorships[7].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | University of Glasgow |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Pardeep S. Jhund |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Pardeep S. Jhund https://orcid.org/0000-0003-4306-5317 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[8].author.id | https://openalex.org/A5009535057 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6333-9496 |
| authorships[8].author.display_name | Mark C. Petrie |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[8].affiliations[0].raw_affiliation_string | Mark C. Petrie https://orcid.org/0000-0002-6333-9496 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[8].institutions[0].id | https://openalex.org/I7882870 |
| authorships[8].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | University of Glasgow |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Mark C. Petrie |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Mark C. Petrie https://orcid.org/0000-0002-6333-9496 School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[9].author.id | https://openalex.org/A5007021966 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8441-6887 |
| authorships[9].author.display_name | Ninian N. Lang |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[9].affiliations[0].raw_affiliation_string | School of Cardiovascular and Metabolic Health, University of Glasgow, 126 University Pl, Glasgow, G12 8TA, United Kingdom. |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I7882870 |
| authorships[9].affiliations[1].raw_affiliation_string | School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom. |
| authorships[9].institutions[0].id | https://openalex.org/I7882870 |
| authorships[9].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | University of Glasgow |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Ninian N. Lang |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | School of Cardiovascular and Metabolic Health (L.M., C.E.J., C.A., P.W., R.C.M., J.J.V.M., P.S.J., M.C.P., N.N.L.), University of Glasgow, United Kingdom., School of Cardiovascular and Metabolic Health, University of Glasgow, 126 University Pl, Glasgow, G12 8TA, United Kingdom. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10198 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Heart Failure Treatment and Management |
| related_works | https://openalex.org/W2011390101, https://openalex.org/W3110630109, https://openalex.org/W3187572025, https://openalex.org/W3155674270, https://openalex.org/W2033060138, https://openalex.org/W2605975631, https://openalex.org/W2059778827, https://openalex.org/W2150981544, https://openalex.org/W2116045608, https://openalex.org/W4376630782 |
| cited_by_count | 41 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 14 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 20 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 7 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1161/circheartfailure.122.010051 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S8311976 |
| best_oa_location.source.issn | 1941-3289, 1941-3297 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1941-3289 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Circulation Heart Failure |
| best_oa_location.source.host_organization | https://openalex.org/P4310315671 |
| best_oa_location.source.host_organization_name | Lippincott Williams & Wilkins |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Circulation: Heart Failure |
| best_oa_location.landing_page_url | https://doi.org/10.1161/circheartfailure.122.010051 |
| primary_location.id | doi:10.1161/circheartfailure.122.010051 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S8311976 |
| primary_location.source.issn | 1941-3289, 1941-3297 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1941-3289 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Circulation Heart Failure |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.122.010051 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Circulation: Heart Failure |
| primary_location.landing_page_url | https://doi.org/10.1161/circheartfailure.122.010051 |
| publication_date | 2023-03-10 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W164205712, https://openalex.org/W1518273993, https://openalex.org/W3160646701, https://openalex.org/W2273857042, https://openalex.org/W3004502136, https://openalex.org/W3045989635, https://openalex.org/W3011669549, https://openalex.org/W2944333322, https://openalex.org/W2344497073, https://openalex.org/W2748400555, https://openalex.org/W2900002398, https://openalex.org/W2347011549, https://openalex.org/W2315070211, https://openalex.org/W3090635289, https://openalex.org/W2089508039, https://openalex.org/W3127671140, https://openalex.org/W1971009979, https://openalex.org/W3134839532, https://openalex.org/W1999478625, https://openalex.org/W2624879349, https://openalex.org/W1984775204, https://openalex.org/W2397911846, https://openalex.org/W3198485697, https://openalex.org/W1967887231, https://openalex.org/W2159513257, https://openalex.org/W2147155927, https://openalex.org/W2100587643, https://openalex.org/W2027390553, https://openalex.org/W1978728606, https://openalex.org/W2126556811, https://openalex.org/W2140655158, https://openalex.org/W3166955588, https://openalex.org/W1506577935, https://openalex.org/W1893887535, https://openalex.org/W2039499065, https://openalex.org/W2118070232, https://openalex.org/W2509379074, https://openalex.org/W2219843464, https://openalex.org/W2888384778, https://openalex.org/W3123997044, https://openalex.org/W2427094903 |
| referenced_works_count | 41 |
| abstract_inverted_index.( | 178 |
| abstract_inverted_index.P | 179 |
| abstract_inverted_index.a | 4, 81, 222 |
| abstract_inverted_index.IL | 74 |
| abstract_inverted_index.In | 148, 251 |
| abstract_inverted_index.T1 | 111, 175 |
| abstract_inverted_index.T2 | 113 |
| abstract_inverted_index.T3 | 116, 162, 173 |
| abstract_inverted_index.We | 16, 41 |
| abstract_inverted_index.an | 264 |
| abstract_inverted_index.at | 25 |
| abstract_inverted_index.in | 6, 60, 80, 107, 122, 161, 172, 185, 217, 287 |
| abstract_inverted_index.is | 263 |
| abstract_inverted_index.of | 9, 21, 28, 104, 152, 192, 225, 244, 267, 284, 290 |
| abstract_inverted_index.or | 247 |
| abstract_inverted_index.286 | 61 |
| abstract_inverted_index.BNP | 89 |
| abstract_inverted_index.One | 181, 213 |
| abstract_inverted_index.T1, | 120 |
| abstract_inverted_index.T1. | 164 |
| abstract_inverted_index.The | 102 |
| abstract_inverted_index.and | 49, 54, 76, 115, 134, 157, 166, 205, 228, 232, 272 |
| abstract_inverted_index.are | 283 |
| abstract_inverted_index.but | 238 |
| abstract_inverted_index.for | 85, 235, 276 |
| abstract_inverted_index.had | 135 |
| abstract_inverted_index.log | 182, 214 |
| abstract_inverted_index.may | 2 |
| abstract_inverted_index.not | 240 |
| abstract_inverted_index.the | 7, 123, 288 |
| abstract_inverted_index.was | 110, 187, 219, 239 |
| abstract_inverted_index.(56% | 131 |
| abstract_inverted_index.1.24 | 209 |
| abstract_inverted_index.1.40 | 203 |
| abstract_inverted_index.1.46 | 197 |
| abstract_inverted_index.35%) | 133 |
| abstract_inverted_index.BNP. | 280 |
| abstract_inverted_index.IL-6 | 105, 125, 186, 262 |
| abstract_inverted_index.drug | 293 |
| abstract_inverted_index.each | 108 |
| abstract_inverted_index.male | 130 |
| abstract_inverted_index.more | 128 |
| abstract_inverted_index.play | 3 |
| abstract_inverted_index.risk | 27, 86, 191, 224, 243, 277 |
| abstract_inverted_index.role | 5 |
| abstract_inverted_index.sHFH | 158, 206, 245, 273 |
| abstract_inverted_index.unit | 183, 215 |
| abstract_inverted_index.were | 78, 99, 127, 159 |
| abstract_inverted_index.with | 12, 33, 36, 65, 68, 119, 189, 221, 242, 255, 258 |
| abstract_inverted_index.(11.6 | 143 |
| abstract_inverted_index.These | 281 |
| abstract_inverted_index.after | 176, 211, 233, 248, 274 |
| abstract_inverted_index.death | 168, 194, 200, 227, 230 |
| abstract_inverted_index.heart | 10, 34, 56, 66, 256 |
| abstract_inverted_index.hsCRP | 95, 142, 218 |
| abstract_inverted_index.model | 83 |
| abstract_inverted_index.other | 236 |
| abstract_inverted_index.range | 103 |
| abstract_inverted_index.rates | 151, 169 |
| abstract_inverted_index.(IL-6) | 46 |
| abstract_inverted_index.(T1-3) | 48 |
| abstract_inverted_index.(sHFH) | 59 |
| abstract_inverted_index.before | 231, 246 |
| abstract_inverted_index.death, | 51, 53, 154, 156, 271 |
| abstract_inverted_index.higher | 136, 160, 171, 190, 223 |
| abstract_inverted_index.levels | 20 |
| abstract_inverted_index.mg/L). | 147 |
| abstract_inverted_index.ratio, | 196, 202, 208 |
| abstract_inverted_index.versus | 132, 139, 145, 163, 174 |
| abstract_inverted_index.(B-type | 90 |
| abstract_inverted_index.(hazard | 195, 201, 207 |
| abstract_inverted_index.(pg/mL) | 106 |
| abstract_inverted_index.101±36 | 140 |
| abstract_inverted_index.adverse | 29 |
| abstract_inverted_index.between | 44, 73 |
| abstract_inverted_index.context | 289 |
| abstract_inverted_index.current | 291 |
| abstract_inverted_index.factors | 87, 237, 278 |
| abstract_inverted_index.failure | 11, 35, 57, 67, 257 |
| abstract_inverted_index.greater | 26 |
| abstract_inverted_index.highest | 124 |
| abstract_inverted_index.tertile | 109, 126 |
| abstract_inverted_index.whether | 18 |
| abstract_inverted_index.(117±45 | 138 |
| abstract_inverted_index.Compared | 118 |
| abstract_inverted_index.Methods: | 40 |
| abstract_inverted_index.Results: | 101 |
| abstract_inverted_index.adjusted | 84 |
| abstract_inverted_index.assessed | 42 |
| abstract_inverted_index.commonly | 129 |
| abstract_inverted_index.ejection | 14, 38, 70, 260 |
| abstract_inverted_index.examined | 17, 79 |
| abstract_inverted_index.findings | 282 |
| abstract_inverted_index.identify | 23 |
| abstract_inverted_index.increase | 184, 216 |
| abstract_inverted_index.outcomes | 30, 77 |
| abstract_inverted_index.patients | 24, 62, 121, 252 |
| abstract_inverted_index.protein) | 98 |
| abstract_inverted_index.recently | 63, 253 |
| abstract_inverted_index.remained | 170 |
| abstract_inverted_index.tertiles | 47 |
| abstract_inverted_index.All-cause | 165 |
| abstract_inverted_index.all-cause | 50, 153, 193, 229, 268 |
| abstract_inverted_index.analysis, | 150 |
| abstract_inverted_index.assessed. | 100 |
| abstract_inverted_index.following | 31 |
| abstract_inverted_index.fraction, | 261 |
| abstract_inverted_index.fraction. | 15, 39, 71 |
| abstract_inverted_index.including | 88, 94, 279 |
| abstract_inverted_index.peptide). | 92 |
| abstract_inverted_index.predictor | 266 |
| abstract_inverted_index.preserved | 13, 37, 69, 259 |
| abstract_inverted_index.relevance | 286 |
| abstract_inverted_index.μmol/L), | 141 |
| abstract_inverted_index.Biomarkers | 93 |
| abstract_inverted_index.C-reactive | 97 |
| abstract_inverted_index.adjustment | 177, 234, 275 |
| abstract_inverted_index.associated | 188, 220, 241 |
| abstract_inverted_index.creatinine | 137 |
| abstract_inverted_index.mortality, | 269 |
| abstract_inverted_index.particular | 285 |
| abstract_inverted_index.subsequent | 55 |
| abstract_inverted_index.<0.001). | 180 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.adjustment. | 212, 249 |
| abstract_inverted_index.anti–IL-6 | 292 |
| abstract_inverted_index.circulating | 19 |
| abstract_inverted_index.independent | 265 |
| abstract_inverted_index.natriuretic | 91 |
| abstract_inverted_index.univariable | 149 |
| abstract_inverted_index.Associations | 72 |
| abstract_inverted_index.Conclusions: | 250 |
| abstract_inverted_index.Inflammation | 1 |
| abstract_inverted_index.development. | 294 |
| abstract_inverted_index.hospitalized | 64, 254 |
| abstract_inverted_index.interleukin-6 | 22, 45 |
| abstract_inverted_index.relationships | 43 |
| abstract_inverted_index.(0.71–4.16), | 112 |
| abstract_inverted_index.(4.20–7.84), | 114 |
| abstract_inverted_index.2.3[1.1–4.2] | 146 |
| abstract_inverted_index.Cox-regression | 82 |
| abstract_inverted_index.[1.01–1.51]) | 210 |
| abstract_inverted_index.cardiovascular | 52, 155, 167, 199, 226, 270 |
| abstract_inverted_index.(7.9–236.32). | 117 |
| abstract_inverted_index.(interleukin)-6 | 75 |
| abstract_inverted_index.[1.10–1.77]), | 204 |
| abstract_inverted_index.[1.17–1.81]), | 198 |
| abstract_inverted_index.hospitalization | 32, 58 |
| abstract_inverted_index.pathophysiology | 8 |
| abstract_inverted_index.[4.9–26.6]mg/L | 144 |
| abstract_inverted_index.(high-sensitivity | 96 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5007021966 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I7882870 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8799999952316284 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.98866023 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |